FDA Inspection 1230084 — Michael Borte, M.D.
The FDA completed an inspection of Michael Borte, M.D. on Dec 6, 2023 in Leipzig. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Leipzig (Germany)
Additional Details
Clinical Investigator (CI)